RXRX's CDK7 inhibitor REC-617 has demonstrated activity, but additional data from the ELUCIDATE trial in various solid tumors ...

Auckland International Airport's Q2 FY25 results show robust growth, but higher capital expenditures and debt pressures ...

A trio of exceptional vehicles from the prestigious Mile High Collection will be auctioned by Mecum Auctions in Houston on ...

In the fast-moving world of robotics we line up the most likely movers and makers vying to control the automated future ...

New Delhi [India], March 24: Shree Ahimsa Naturals Limited has announced its plan to go public with an Initial Public Offering (IPO) on March 25, 2025, aiming to raise up to Rs.73.81 Cr with shares to ...

Continued execution across Ampligen® (rintatolimod) clinical development programs in areas with critical unmet needs, especially in the ...

Continued execution across Ampligen® (rintatolimod) clinical development programs in areas with critical unmet needs, especially in the high-value pancreatic cancer space Expected milestones over the ...

This can be seen in its five-year alpha calculated relative to the category index, which suggests that the process has struggled over that period. The parent firm's subpar risk-adjusted ...

EXAE.AT Hellenic Exchanges - Athens Stock Exchange S.A.

SUTNY Sumitomo Mitsui Trust Group, Inc.